Clinical Laserthermia Systems AB (publ) (CLS-B.ST) Research

Founded in 2006 and based in Lund, Sweden, Clinical Laserthermia Systems AB (publ) specializes in crafting therapeutic instruments for treating diseased tissues, marketed under their TRANBERG brand. A core offering is the TRANBERG thermal therapy system, engineered to precisely deliver laser energy for heating targeted tissue. Their product range also features a mobile laser unit, an essential control component that operates at a 1064-nanometer wavelength, providing flexible options for treatment management. Additionally, the company supplies a variety of laser applicators in different gauges, alongside advanced devices for monitoring both temperature and the treatment's progress.

Market snapshot

Symbol
CLS-B.ST
Price
$3.58
Day change
0.00%
Market cap
$92.5M
P/E ratio
-2.98x
52-week range
2.695-13.36
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Annexin Pharmaceuticals AB (publ) (ANNX.ST)
  • Boule Diagnostics AB (publ) (BOUL.ST)
  • BrainCool AB (publ) (BRAIN.ST)
  • Enorama Pharma AB (publ) (ERMA.ST)
  • Integrum AB (publ) (INTEG-B.ST)
  • Isofol Medical AB (publ) (ISOFOL.ST)
  • iZafe Group AB (publ) (IZAFE-B.ST)
  • Lipum AB (publ) (LIPUM.ST)

Open Clinical Laserthermia Systems AB (publ) (CLS-B.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.